• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激酶配体亲和力预测中活性位点序列的选择。

On the Choice of Active Site Sequences for Kinase-Ligand Affinity Prediction.

机构信息

Accelerated Discovery, IBM Research Europe, 8803 Rüschlikon, Switzerland.

Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.

出版信息

J Chem Inf Model. 2022 Sep 26;62(18):4295-4299. doi: 10.1021/acs.jcim.2c00840. Epub 2022 Sep 13.

DOI:10.1021/acs.jcim.2c00840
PMID:36098536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9516689/
Abstract

Recent work showed that active site rather than full-protein-sequence information improves predictive performance in kinase-ligand binding affinity prediction. To refine the notion of an "active site", we here propose and compare multiple definitions. We report significant evidence that our novel definition is superior to previous definitions and better models of ATP-noncompetitive inhibitors. Moreover, we leverage the discontiguity of the active site sequence to motivate novel protein-sequence augmentation strategies and find that combining them further improves performance.

摘要

最近的研究表明,在激酶-配体结合亲和力预测中,活性位点而不是完整的蛋白质序列信息可以提高预测性能。为了完善“活性位点”的概念,我们在这里提出并比较了多种定义。我们有充分的证据表明,我们的新定义优于以前的定义,并且更好地模拟了非竞争性 ATP 抑制剂。此外,我们利用活性位点序列的不连续性来激发新的蛋白质序列增强策略,并发现将它们结合使用可以进一步提高性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2210/9516689/dcd78533f461/ci2c00840_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2210/9516689/5867d6dc55c1/ci2c00840_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2210/9516689/dcd78533f461/ci2c00840_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2210/9516689/5867d6dc55c1/ci2c00840_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2210/9516689/dcd78533f461/ci2c00840_0002.jpg

相似文献

1
On the Choice of Active Site Sequences for Kinase-Ligand Affinity Prediction.激酶配体亲和力预测中活性位点序列的选择。
J Chem Inf Model. 2022 Sep 26;62(18):4295-4299. doi: 10.1021/acs.jcim.2c00840. Epub 2022 Sep 13.
2
Active Site Sequence Representations of Human Kinases Outperform Full Sequence Representations for Affinity Prediction and Inhibitor Generation: 3D Effects in a 1D Model.人源激酶活性位点序列表示优于全序列表示,可用于亲和力预测和抑制剂生成:1D 模型中的 3D 效应。
J Chem Inf Model. 2022 Jan 24;62(2):240-257. doi: 10.1021/acs.jcim.1c00889. Epub 2021 Dec 14.
3
Converting a weaker ATP-binding site inhibitor into a potent hetero-bivalent ligand by tethering to a unique peptide sequence derived from the same kinase.通过与同一激酶衍生的独特肽序列连接,将较弱的 ATP 结合位点抑制剂转化为有效的杂双价配体。
Org Biomol Chem. 2018 Sep 11;16(35):6443-6449. doi: 10.1039/c8ob01406j.
4
Allosteric Effect of Adenosine Triphosphate on Peptide Recognition by 3'5'-Cyclic Adenosine Monophosphate Dependent Protein Kinase Catalytic Subunits.三磷酸腺苷对3',5'-环磷酸腺苷依赖性蛋白激酶催化亚基肽识别的变构效应
Protein J. 2016 Dec;35(6):459-466. doi: 10.1007/s10930-016-9691-9.
5
Analysis of c-Met kinase domain complexes: a new specific catalytic site receptor model for defining binding modes of ATP-competitive ligands.分析 c-Met 激酶结构域复合物:一种新的特定催化位点受体模型,用于定义 ATP 竞争配体的结合模式。
Chem Biol Drug Des. 2009 Dec;74(6):560-70. doi: 10.1111/j.1747-0285.2009.00895.x.
6
A novel computational analysis of ligand-induced conformational changes in the ATP binding sites of cyclin dependent kinases.细胞周期蛋白依赖性激酶ATP结合位点中配体诱导的构象变化的新型计算分析
J Med Chem. 2006 Sep 7;49(18):5434-41. doi: 10.1021/jm060172s.
7
Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands.基于包含生理和合成配体的人丙酮酸脱氢酶激酶2晶体结构的N端结构域的调控作用。
Biochemistry. 2006 Jan 17;45(2):402-15. doi: 10.1021/bi051402s.
8
Study of the substrate-binding properties of bovine liver adenosine kinase and inhibition by fluorescent nucleoside analogues.牛肝腺苷激酶的底物结合特性及荧光核苷类似物抑制作用的研究
Eur J Biochem. 1997 Sep 15;248(3):930-7. doi: 10.1111/j.1432-1033.1997.00930.x.
9
Characteristics of the Plasmodium falciparum PK5 ATP-binding site: implications for the design of novel antimalarial agents.恶性疟原虫PK5 ATP结合位点的特征:对新型抗疟药物设计的启示
J Mol Graph Model. 2004 Jan;22(3):241-7. doi: 10.1016/j.jmgm.2003.09.002.
10
Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.发现并鉴定有丝分裂原激活蛋白(MAP)激酶非 ATP 结合位点抑制剂。
ACS Chem Biol. 2011 Mar 18;6(3):234-44. doi: 10.1021/cb1002619. Epub 2011 Jan 20.

本文引用的文献

1
On the Frustration to Predict Binding Affinities from Protein-Ligand Structures with Deep Neural Networks.从蛋白质-配体结构用深度神经网络预测结合亲和力的挫折。
J Med Chem. 2022 Jun 9;65(11):7946-7958. doi: 10.1021/acs.jmedchem.2c00487. Epub 2022 May 24.
2
Active Site Sequence Representations of Human Kinases Outperform Full Sequence Representations for Affinity Prediction and Inhibitor Generation: 3D Effects in a 1D Model.人源激酶活性位点序列表示优于全序列表示,可用于亲和力预测和抑制剂生成:1D 模型中的 3D 效应。
J Chem Inf Model. 2022 Jan 24;62(2):240-257. doi: 10.1021/acs.jcim.1c00889. Epub 2021 Dec 14.
3
Improved Protein-Ligand Binding Affinity Prediction with Structure-Based Deep Fusion Inference.
基于结构的深度融合推理提高蛋白-配体结合亲和力预测。
J Chem Inf Model. 2021 Apr 26;61(4):1583-1592. doi: 10.1021/acs.jcim.0c01306. Epub 2021 Mar 23.
4
Deep Learning in Drug Target Interaction Prediction: Current and Future Perspectives.深度学习在药物靶点相互作用预测中的应用:现状与未来展望。
Curr Med Chem. 2021;28(11):2100-2113. doi: 10.2174/0929867327666200907141016.
5
RosENet: Improving Binding Affinity Prediction by Leveraging Molecular Mechanics Energies with an Ensemble of 3D Convolutional Neural Networks.RosENet:利用 3D 卷积神经网络集成提高结合亲和力预测的分子力学能量。
J Chem Inf Model. 2020 Jun 22;60(6):2791-2802. doi: 10.1021/acs.jcim.0c00075. Epub 2020 May 26.
6
DeepAffinity: interpretable deep learning of compound-protein affinity through unified recurrent and convolutional neural networks.DeepAffinity:通过统一的递归和卷积神经网络实现化合物-蛋白质亲和力的可解释深度学习。
Bioinformatics. 2019 Sep 15;35(18):3329-3338. doi: 10.1093/bioinformatics/btz111.
7
MEK1/2 Inhibitors: Molecular Activity and Resistance Mechanisms.MEK1/2抑制剂:分子活性与耐药机制
Semin Oncol. 2015 Dec;42(6):849-62. doi: 10.1053/j.seminoncol.2015.09.023. Epub 2015 Sep 24.
8
BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology.2015年的BindingDB:一个用于药物化学、计算化学和系统药理学的公共数据库。
Nucleic Acids Res. 2016 Jan 4;44(D1):D1045-53. doi: 10.1093/nar/gkv1072. Epub 2015 Oct 19.
9
Kinases and pseudokinases: lessons from RAF.激酶和拟激酶:从 RAF 中得到的启示。
Mol Cell Biol. 2014 May;34(9):1538-46. doi: 10.1128/MCB.00057-14. Epub 2014 Feb 24.
10
Kinase-kernel models: accurate in silico screening of 4 million compounds across the entire human kinome.激酶-核模型:对整个人类激酶组中的 400 万种化合物进行准确的计算机筛选。
J Chem Inf Model. 2012 Jan 23;52(1):156-70. doi: 10.1021/ci200314j. Epub 2012 Jan 6.